CD4 and neoplasm: The correlation analysis and the immunological and clinical outcomes of rBCG immunotherapy underscores the pivotal role of orchestrated interactions between CD4+ T cells, CD8+ T cells, and dendritic cells in shaping the tumor microenvironment.